Express News | Aditxt Announces Third Amendment to Arrangement Agreement With Appili Therapeutics
Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction With Aditxt
Evofem Biosciences Addresses Impact Of GLP-1 Medications On Oral Contraceptive Absorption And Introduces Phexxi As A Non-Oral Solution
Aditxt | 10-Q: Q2 2024 Earnings Report
Looking Into Aditxt's Recent Short Interest
Evofem Biosciences Had $700,000 of Restricted Cash at June 30 >EVFM
Evofem Biosciences 2Q EPS 0c >EVFM
Express News | Evofem Biosciences Announces Financial Results for the Second Quarter of 2024
Appili Therapeutics Brief: Says Definitive Agreement With Aditxt, If Approved by Appili Shareholders, "Provides Significant Premium to Shareholders and Resources to Advance Key Programs"
Express News | Aditxt Announces the Successful Passage of All Proposals at Recent Annual Shareholders’ Meeting, Setting the Stage for 2024 and 2025 Strategic Plans
Express News | Aditxt Announces Closing of $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Aditxt Sells 1.13M Shares at $1.06 in Registered Direct Offering
Express News | Aditxt Announces $1.2 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
G1 Therapeutics GTHX Acquired by Pharmacosmos; Aditxt ADTX DoD Proposal
Biotech Stock Soars Despite Broader Selloff
Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates
Express News | Aditxt Subsidiary Pearsanta Submits Proposal For Clinical Trial Translational Endpoints Research Award To The Congressionally Directed Medical Research Programs Of The Department of Defense
Aditxt Subsidiary Pearsanta Seeks Clinical Trial Translational Endpoints Research Award for Early Detection of Ovarian Cancer
Express News | Aditxt Inc - Transaction Is Conditional Upon Aditxt Raising at Least US$20 Mln in Financing Before Closing
Aditxt Signs Second Amendment to the Arrangement Agreement With Appili Therapeutics, Targeting September 30 Closing of the Acquisition
No Data